×

Ariad CEO talks Iclusig trials

12:34 PM ET Mon, 2 June 2014

Ariad Pharmaceuticals CEO Dr. Harvey Berger, says investors are responding to his company's better overall picture, and the progress on its leukemia drug Iclusig.